Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.

低鼠源抗体引起的超敏反应,治疗性单克隆抗体已由改型抗体,源化抗体展到全抗体。